Fenlu Zhu

Bispecific anti-CD20, anti-CD19 CAR T cells for relapsed B cell malignancies: a phase 1 dose escalation and expansion trial

Nirav N. Shah, Bryon D. Johnson, Dina Schneider et al. · Nature Medicine · 2020 · 439 citations

Cancer Immunosurveillance, Dose Escalation, Medicine +7

Closed-system manufacturing of CD19 and dual-targeted CD20/19 chimeric antigen receptor T cells using the CliniMACS Prodigy device at an academic medical center

Fenlu Zhu, Nirav N. Shah, Huiqing Xu et al. · Cytotherapy · 2017 · 116 citations

Closed-system Manufacturing, Medicine, Academic Medical Center +10

Tocilizumab, tacrolimus and methotrexate for the prevention of acute graft- <i>versus</i> -host disease: low incidence of lower gastrointestinal tract disease

William R. Drobyski, Anikó Szabó, Fenlu Zhu et al. · Haematologica · 2018 · 49 citations · Full text

Results of a phase I study of bispecific anti-CD19, anti-CD20 chimeric antigen receptor (CAR) modified T cells for relapsed, refractory, non-Hodgkin lymphoma.

Nirav N. Shah, Fenlu Zhu, Dina Schneider et al. · Journal of Clinical Oncology · 2019 · 42 citations

Cd19 Negative Relapse, Immunology, Immunoediting +18

A colitogenic memory CD4+ T cell population mediates gastrointestinal graft-versus-host disease

Vivian Zhou, Kimberle A. Agle, Amy Beres et al. · Journal of Clinical Investigation · 2016 · 32 citations · Full text